These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 23014256

  • 1. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
    Kota SK, Meher LK, Jammula S, Kota SK, Modi KD.
    Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
    [Abstract] [Full Text] [Related]

  • 2. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
    Song J, Yang Y, Mauvais-Jarvis F, Wang YP, Niu T.
    BMC Med Genet; 2017 Jun 06; 18(1):64. PubMed ID: 28587604
    [Abstract] [Full Text] [Related]

  • 3. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population.
    Gonen MS, Arikoglu H, Erkoc Kaya D, Ozdemir H, Ipekci SH, Arslan A, Kayis SA, Gogebakan B.
    Arch Med Res; 2012 May 06; 43(4):317-23. PubMed ID: 22704848
    [Abstract] [Full Text] [Related]

  • 4. Monogenic models: what have the single gene disorders taught us?
    Klupa T, Skupien J, Malecki MT.
    Curr Diab Rep; 2012 Dec 06; 12(6):659-66. PubMed ID: 22996131
    [Abstract] [Full Text] [Related]

  • 5. Heterozygous ABCC8 mutations are a cause of MODY.
    Bowman P, Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R, Hattersley AT, Ellard S.
    Diabetologia; 2012 Jan 06; 55(1):123-7. PubMed ID: 21989597
    [Abstract] [Full Text] [Related]

  • 6. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population.
    Wang F, Han XY, Ren Q, Zhang XY, Han LC, Luo YY, Zhou XH, Ji LN.
    Chin Med J (Engl); 2009 Oct 20; 122(20):2477-82. PubMed ID: 20079163
    [Abstract] [Full Text] [Related]

  • 7. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
    Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Nathan DM, Altshuler D.
    Diabetes; 2007 Feb 20; 56(2):531-6. PubMed ID: 17259403
    [Abstract] [Full Text] [Related]

  • 8. Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus.
    Reis AF, Velho G.
    Diabetes Metab; 2002 Feb 20; 28(1):14-9. PubMed ID: 11938023
    [Abstract] [Full Text] [Related]

  • 9. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
    Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT, Neonatal Diabetes International Collaborative Group.
    Diabetes Care; 2008 Feb 20; 31(2):204-9. PubMed ID: 18025408
    [Abstract] [Full Text] [Related]

  • 10. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P, Arnold AL, Bruining J, Girard C, Flanagan SE, Larkin B, Colclough K, Hattersley AT, Ashcroft FM, Ellard S.
    Hum Mol Genet; 2006 Jun 01; 15(11):1793-800. PubMed ID: 16613899
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
    Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, Ciljakova M, Hlava P, Michalek J, Flanagan SE, Pearson E, Hattersley AT, Ellard S, Klimes I.
    J Clin Endocrinol Metab; 2007 Apr 01; 92(4):1276-82. PubMed ID: 17213273
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacogenetics of insulin secretagogue antidiabetics].
    Winkler G, Gerô L.
    Orv Hetil; 2011 Oct 09; 152(41):1651-60. PubMed ID: 21959939
    [Abstract] [Full Text] [Related]

  • 13. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.
    Zychma MJ, Gumprecht J, Strojek K, Grzeszczak W, Moczulski D, Trautsolt W, Karasek D.
    Med Sci Monit; 2002 Jul 09; 8(7):CR512-5. PubMed ID: 12118200
    [Abstract] [Full Text] [Related]

  • 14. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
    Oztekin O, Durmaz E, Kalay S, Flanagan SE, Ellard S, Bircan I.
    J Perinatol; 2012 Aug 09; 32(8):645-7. PubMed ID: 22842804
    [Abstract] [Full Text] [Related]

  • 15. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
    Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC, UK Prospective Diabetes Study (UKPDS 53).
    Diabet Med; 2001 Mar 09; 18(3):206-12. PubMed ID: 11318841
    [Abstract] [Full Text] [Related]

  • 16. Genetics of type 2 diabetes mellitus: status and perspectives.
    Hansen L, Pedersen O.
    Diabetes Obes Metab; 2005 Mar 09; 7(2):122-35. PubMed ID: 15715885
    [Abstract] [Full Text] [Related]

  • 17. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
    Gloyn AL, Siddiqui J, Ellard S.
    Hum Mutat; 2006 Mar 09; 27(3):220-31. PubMed ID: 16416420
    [Abstract] [Full Text] [Related]

  • 18. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region.
    Florez JC, Burtt N, de Bakker PI, Almgren P, Tuomi T, Holmkvist J, Gaudet D, Hudson TJ, Schaffner SF, Daly MJ, Hirschhorn JN, Groop L, Altshuler D.
    Diabetes; 2004 May 09; 53(5):1360-8. PubMed ID: 15111507
    [Abstract] [Full Text] [Related]

  • 19. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
    Jahnavi S, Poovazhagi V, Mohan V, Bodhini D, Raghupathy P, Amutha A, Suresh Kumar P, Adhikari P, Shriraam M, Kaur T, Das AK, Molnes J, Njolstad PR, Unnikrishnan R, Radha V.
    Clin Genet; 2013 May 09; 83(5):439-45. PubMed ID: 22831748
    [Abstract] [Full Text] [Related]

  • 20. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R, Koster JC, Tumini S, Chiarelli F, Colombo C, Nichols CG, Barbetti F.
    Diabetes; 2007 Feb 09; 56(2):328-36. PubMed ID: 17259376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.